Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases

Food and Chemical Toxicology

Volumn 61, Issue , 2013, Pages 215-226

  Carrizzo, Albino ^a   Forte, Maurizio ^b   Damato, Antonio ^a   Trimarco, Valentina ^b   Salzano, Francesco ^c   Bartolo, Michelangelo ^a   Maciag, Anna ^d   Puca, Annibale A ^d,e   Vecchione, Carmine ^a,e  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

^e UNIVERSITY OF SALERNO   (Italy)

Author keywords

Antioxidant; Brain; Cardiovascular; Diabetes; Nitric oxide; Oxidative stress

Indexed keywords

8 ISOPROSTANE; ALPHA TOCOPHEROL; CATALASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PLACEBO; POLYGONUM CUSPIDATUM EXTRACT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2;

ABDOMINAL PAIN; ALZHEIMER DISEASE; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DIARRHEA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG STRUCTURE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; LIPID PEROXIDATION; LOW DRUG DOSE; METABOLIC DISORDER; NAUSEA; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PLASMA HALF LIFE; THROMBOCYTE AGGREGATION INHIBITION;

ANTIOXIDANT; BRAIN; CARDIOVASCULAR; DIABETES; NITRIC OXIDE; OXIDATIVE STRESS;

ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; HUMANS; METABOLIC DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; STILBENES;

EID: 84888855862     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.07.021     Document Type: Article

References (179)

1. Alcaín F.J., Villalba J.M. Sirtuin activators. Expert Opin. Ther. Pat. 2009, 19(4):403-414.
2. Alissa E.M., Ferns G.A. Functional foods and nutraceuticals in the primary prevention of cardiovascular diseases. J. Nutr. Metab. 2012, 2012:569486.
3. Almeida L., Vaz-da-Silva M., Falcao A., Soares E., Costa R., Loureiro A.I., Fernandes-Lopes C., Rocha J.F., Nunes T., Wright L., Soares-da-Silva P. Pharmacokinetic and safety profile of transresveratrol in a rising multiple-dose study in healthy volunteers. Mol. Nutr. Food. 2009, 53(1):S7-S15.
4. Andres-Lacueva, C., Urpi-Sarda, M., Zamora-Ros, R., Lamuela-Raventos, R.M., 2009. In: Fraga, C.G. (Ed.), Plant Phenolics and Human Health: Biochemistry, Nutrition and, Pharmacology. pp. 265-299.
5. Appeldoorn M.M., Venema D.P., Peters T.H., Koenen M.E., Arts I.C.W., Vincken J.P., Gruppen H., Keijer J., Hollman P.C. Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. J. Agric. Food Chem. 2009, 57:7693-7699.
6. Azorín-Ortuño M., Yáñez-Gascón M.J., Vallejo F., Pallarés F.J., Larrosa M., Lucas R., Morales J.C., Tomás-Barberán F.A., García-Conesa M.T., Espín J.C. Metabolites and tissue distribution of resveratrol in the pig. Mol. Nutr. Food Res. 2011, 55(8):1154-1168.
7. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
8. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
9. Bhavnani B.R., Cecutti A., Gerulath A., Woolever A.C., Berco M. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause 2001, 8:408-419.
10. Bo S., Ciccone G., Castiglione A., Gambino R., De Michieli F., Villois P., Durazzo M., Cavallo-Perin P., Cassader M. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial. Curr. Med. Chem. 2013, 20(10):1323-1331.
11. Boocock D.J., Patel K.R., Faust G.E., Normolle D.P., Marczylo T.H., Crowell J.A., Brenner D.E., Booth T.D., Gescher A., Steward W.P. Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 848:182-187.
12. Borriello A., Cucciolla V., Della Ragione F., Galletti P. Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr. Metab. Cardiovasc. Dis. 2010, 20(8):618-625.
13. Brasnyo P., Molnar G.A., Mohas M., Marko L., Laczy B., Cseh J., Mikolas E., Szijarto I.A., Merei A., Halmai R., Meszaros L.G., Sumegi B., Wittmann I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 1-7.
14. Brown V., Patel K., Viskaduraki M., Crowell J.A., Perloff M., Booth T.D., Vasilinin G., Sen A., Schinas A.M., Piccirilli G., Brown K., Steward W.P., Gescher A.J., Brenner D.E. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics and effect on the insulin-like growth factor axis. Cancer Res. 2010, 70(22):9003-9011.
15. Calamini B., Ratia K., Malkowski M.G., Cuendet M., Pezzuto J.M., Santarsiero B.D., Mesecar A.D. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem. J. 2010, 429:273-282.
16. Candelario-Jalil E., de Oliveira A.C., Gräf S., Bhatia H.S., Hüll M., Muñoz E., Fiebich B.L. Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J. Neuroinflammation 2007, 4:25.
17. Cao Z., Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 2004, 489:39-48.
18. Carrizzo, A., Puca, A., Damato, A., Marino, M., Franco, E., Pompeo, F., Traficante, A., Civitillo, F., Santini, L., Trimarco, V., Vecchione, C., 2013. Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension (Epub ahead of print).
19. Caruso F., Tanski J., Villegas-Estrada A., Rossi M. Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. J Agric Food Chem 2004, 52:7279-7285.
20. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., Da Ros R., Motz E. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002, 106:1211-1218.
21. Chen C.K., Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol. 1996, 27:363-366.
22. Chen Z.H., Hurh Y.J., Na H.K., Kim J.H., Chun Y.J., Kim D.H., et al. Resveratrol inhibits TCDD induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004, 25:2005-2013.
23. Chen C.Y., Jang J.H., Li M.H., Surh Y.J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun. 2005, 331(4):993-1000.
24. Chow H.H., Garland L.L., Hsu C.H., Vining D.R., Chew W.M., Miller J.A., Perloff M., Crowell J.A., Alberts D.S. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. 2010, 3:1168-1175.
25. Conti V., Corbi G., Russomanno G., Simeon V., Ferrara N., Filippelli W., Limongelli F., Canonico R., Grasso C., Stiuso P., Dicitore A., Filippelli A. Oxidative stress effects on endothelial cells treated with different athletes' sera. Med. Sci. Sports Exerc. 2012, 44(1):39-49.
26. Davinelli S., Sapere N., Zella D., Bracale R., Intrieri M., Scapagnini G. Effects of phytochemicals in Alzheimer's disease. Oxid. Med. Cell. Longev. 2012, 10.1155/2012/386527.
27. de la Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 2007, 35(5):1156-1160.
28. Dudka J., Gieroba R., Korga A., Burdan F., Matysiak W., Jodlowska-Jedrych B., Mandziuk S., Korobowicz E., Murias M. Different effects of resveratrol on dose-related doxorubicin-induced heart and liver toxicity. Evid. Based Complement. Alternat. Med. 2012, 2012:606183.
29. Dudzinski D.M., Michel T. Life history of eNOS: partners and pathways. Cardiovasc. Res. 2007, 75:247-260.
30. Dudzinski D.M., Igarashi J., Greif D., Michel T. The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol. 2006, 46:235-276.
31. Fang J.G., Zhou B. Structure-activity relationship and mechanism of the tocopherol-regenerating activity of resveratrol and its analogues. J. Agric. Food Chem. 2008, 56:11458-11463.
32. Fang J.G., Lu M., Chen Z.H., Zhu H.H., Li Y., Yang L., Wu L.M., Liu Z.L. Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Chemistry 2002, 8:4191-4198.
33. Fauconneau B., Waffo-Teguo P., Huguet F., Barrier L., Decendit A., Merillon J.M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 1997, 61:2103-2110.
34. Feijóo O., Moreno A., Falqué E. Content of trans- and cis-resveratrol in Galician white and red wines. J. Food Compost Anal. 2008, 21:608-613.
35. Feng Y., Wang X.P., Yang S.G., Wang Y.J., Zhang X., Du X.T., Sun X.X., Zhao M., Huang L., Liu R.T. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 2009, 30(6):986-995.
36. Franco J.G., Lisboa P.C., Lima N.S., Amaral T.A., Peixoto-Silva N., Resende A.C., Oliveira E., Passos M.C., Moura E.G. Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning. J. Nutr. Biochem. 2013, 24(6):960-966.
37. Frankel E.N., Waterhouse A.L. Inhibition of human LDL oxidation by resveratrol. Lancet 1993, 341:1103-1104.
38. Fremont L. Biological effects of resveratrol. Life Sci. 2000, 66:663-673.
39. Fremont L., Belguendouz L., Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 1999, 64:2511-2521.
40. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., Anversa P. Myocardial cell death in human diabetes. Circ. Res. 2000, 87:1123-1132.
41. Fukui M., Choi H.J., Ting Z.B. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 2010, 49(5):800-813.
42. Gao X., Belmadani S., Picchi A., Xu X., Potter B.J., Tewari-Singh N., Capobianco S., Chilian W.M., Zhangn C. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 2007, 115:245-254.
43. Gentile M.T., Poulet R., Di Pardo A., Cifelli G., Maffei A., Vecchione C., Passarelli F., Landolfi A., Carullo P., Lembo G. Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiol. Aging 2009, 30(2):222-228.
44. Gescher A.J., Steward W.P. Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol. Biomarkers Prev. 2003, 12:953-957.
45. Ghanim H., Sia C.L., Abuaysheh S., Korzeniewski K., Patnaik P., Marumganti A., Chaudhuri A., Dandona P. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J. Clin. Endocrinol. Metab. 2010, 95:E1-E8.
46. Ghanim H., Sia C.L., Korzeniewski K., Lohano T., Abuaysheh S., Marumganti A., Chaudhuri A., Dandona P. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab. 2011, 96:1409-1414.
47. Goldberg D.M., Yan J., Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 2003, 36:79-87.
48. Han Y.S., Zheng W.H., Bastianetto S., Chabot J.G., Quirion R. Neuroprotective effects of resveratrol against β-amyloid induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br. J. Pharmacol. 2004, 141(6):997-1005.
49. Hart, N.,Sarga, L.,Csende, Z.,Koltai, E.,Koch, L.G.,Britton, S.L.,Davies, K.J.,Kouretas, D.,Wessner, B.,Radak, Z., 2013. Resveratrol enhances exercise training responses in rats selectively bred for high running performance. Food Chem. Toxicol. (Epub ahead of print).
50. Hattori R., Otani H., Maulik N., Das D.K. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1988-H1995.
51. He Y.G., Sun Y.J., Xie Y.X., Zheng H., Zhang Y.D., Guo J., Xi J.K. Resveratrol attenuates oxidant-induced mitochondrial damage in embryonic rat cardiomyocytes via inactivating GSK-3β. Zhonghua. Xin. Xue. Guan. Bing. Za. Zhi. 2012, 40(10):858-863.
52. Hebbar V., Shen G., Hu R., Kim B.R., Chen C., Korytko P.J., Crowell J.A., Levine B.S., Kong A.N. Toxicogenomics of resveratrol in rat liver. Life Sci. 2005, 76:2299-2314.
53. Holvoet P. Oxidized LDL and coronary heart disease. Acta Cardiol. 2004, 59:479-484.
54. Howells L.M., Berry D.P., Elliott P.J., Jacobson E.W., Hoffmann E., Hegarty B., Brown K., Steward W.P., Gescher A.J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics, and pharmacodynamics. Cancer Prevention Res. 2011, 4:1419-1425.
55. Howlett J., Ashwell M. Glycemic response and health: summary of a workshop. Am. J. Clin. Nutr. 2008, 87:212S-216S.
56. Inoue H., Jiang X.F., Katayama T., Osada S., Umesono K., Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice. Neurosci. Lett. 2003, 352:203-206.
57. Jang J.H., Surh Y.J. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat. Res. 2001, 496:181-190.
58. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
59. Jian B., Yang S., Chaudry I.H., Raju R. Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1. Mol. Med. 2012, 18:209-214.
60. Johnson J.J., Nihal M., Siddiqui I.A., Scarlett C.O., Bailey H.H., Mukhtar H., Ahmad N. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol. Nutr. Food Res. 2011, 55:1169-1176.
61. Juan M.E., Vinardell M.P., Planas J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 2002, 132:257-260.
62. Juan S.H., Cheng T.H., Lin H.C., Chu Y.L., Lee W.S. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem. Pharmacol. 2005, 69(1):41-48.
63. Juan M.E., Maijo M., Planas J.M. Quantification of transresveratrol and its metabolites in rat plasma and tissues by HPLC. J. Pharm. Biomed. Anal. 2010, 51:391-398.
64. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 2009, 54(2):111-118.
65. Kelsey N.A., Wilkins H.M., Linseman D.A. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010, 15(11):7792-7814.
66. Kern T.S. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007, 2007:95103.
67. Kim Y.A., Lim S.Y., Rhee S.H., Park K.Y., Kim C.H., Choi B.T., Lee S.J., Park Y.M., Choi Y.H. Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in β-amyloid-treated C6 glioma cells. Int. J. Mol. Med. 2006, 17(6):1069-1075.
68. Kimura T., Takagi H., Suzuma K., Kita M., Watanabe D., Yoshimura N. Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia induced retinal neovascularization. Free Radic. Biol. Med. 2007, 43:454-461.
69. Kitada M., Kume S., Imaizumi N., Koya D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 2011, 60(2):634-643.
70. Klinge C.M., Blankenship K.A., Risinger K.E., Bhatnagar S., Noisin E.L., Sumanasekera W.K., Zhao L., Brey D.M., Keynton R.S. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors α and β in endothelial cells. J. Biol. Chem. 2005, 280:7460-7468.
71. Klinge C.M., Wickramasinghe N.S., Ivanova M.M., Dougherty S.M. Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. Faseb J. 2008, 22(7):2185-2197.
72. Kohnen S., Franck T., Van Antwerpen P., Boudjeltia K.Z., Mouithys-Mickalad A., Deby C., Moguilevsky N., Deby-Dupont G., Lamy M., Serteyn D. Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme. J. Agric. Food Chem. 2007, 55(20):8080-8087.
73. Kovanen P.T., Pentikaïnen M.O. Circulating lipoproteins as proinflammatory and anti-inflammatory particles in atherogenesis. Curr. Opin. Lipidol. 2003, 14:411-419.
74. Kowluru R.A., Chan P.S. Oxidative stress and diabetic retinopathy. Exp. Diabetes Res. 2007, 2007:43603.
75. Kubota S., Kurihara T., Mochimaru H., Satofuka S., Noda K., Ozawa Y., Oike Y., Ishida S., Tsubota K. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest. Ophthalmol. Vis. Sci. 2009, 50:3512-3519.
76. Kumar A., Naidu P.S., Seghal N., Padi S.S.V. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 2007, 79(1):17-26.
77. la Porte C., Voduc N., Zhang G., Seguin I., Tardiff D., Singhal N., Cameron D.W. Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin. Pharmacokinet. 2010, 49:449-454.
78. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127:1109-1122.
79. Lasa A., Churruca I., Eseberri I., Andrés-Lacueva C., Portillo M.P. Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol. Nutr. Food Res. 2012, 56(10):1559-1568.
80. Lee J.H., Song M.Y., Song E.K., Kim E.K., Moon W.S., Han M.K., Park J.W., Kwon K.B., Park B.H. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009, 58:344-351.
81. Lee S.M., Yang H., Tartar D.M., Gao B., Luo X., Ye S.Q., Zaghouani H., Fang D. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia 2011, 54:1136-1146.
82. Leighton F., Cuevas A., Guasch V., Perez D.D., Strobel P., San Martin A., Urzua U., Díez M.S., Foncea R., Castillo O., Mizón C., Espinoza M.A., Urquiaga I., Rozowski J., Maiz A., Germain A. Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans. Drug Exp. Clin. Res. 1999, 25:133-141.
83. Li Y., Cao Z., Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol. Res. 2006, 53(1):6-15.
84. Li, H., Xia, N., Förstermann, U., 2012. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide. 2012 Feb 15;26(2):102-10.
85. Li, H., Horke, S., Förstermann, U., 2013. Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol. Sci. (Epub ahead of print).
86. Liu J.C., Chen J.J., Chan P., Cheng C.F., Cheng T.H. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 2003, 42:1198-1205.
87. Liu B.L., Zhang X., Zhang W., Zhen H.N. New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol. Ther. 2007, 6:1833-1836.
88. Losa G.A. Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. Eur. J. Clin. Invest. 2003, 33:818-823.
89. Lu X.L., Ma L., Ruan L., Kong Y., Mou H., Zhang Z., Wang Z., Wang J.M., Le Y. Resveratrol differentially modulates inflammatory responses of microglia and astrocytes. J. Neuroinflammation 2010, 7:46.
90. Maccarrone M., Lorenzon T., Guerrieri P., Agro A.F. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 1999, 265:27-34.
91. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 2000, 164:6509-6519.
92. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides. J. Biol. Chem. 2005, 280(45):37377-37382.
93. Marier J.F., Vachon P., Gritsas A., Zhang J., Moreau J.P., Ducharme M.P. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 2002, 302:369-373.
94. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
95. Meng X., Maliakal P., Lu H., Lee M.J., Yang C.S. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem. 2004, 52:935-942.
96. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 2000, 59:865-870.
97. Mietus-Snyder M., Gowri M.S., Pitas R.E. Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J. Biol. Chem. 2000, 275:17661-17670.
98. Miller N.J., Rice-Evans C.A. Antioxidant activity of resveratrol in red wine. Clin. Chem. 1995, 41:1789.
99. Miura T., Muraoka S., Ikeda N., Watanabe M., Fujimoto Y. Antioxidative and prooxidative action of stilbene derivatives. Pharmacol. Toxicol. 2000, 86:203-208.
100. Mizutani K., Ikeda K., Kawai Y., Yamori Y. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2001, 28:55-59.
101. Mokni M., Elkahoui S., Limam F., Amri M., Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem. Res. 2007, 32(6):981-987.
102. Morrow J.D., Frei B., Longmire A.W., Gaziano J.M., Lynch S.M., Shyr Y., Strauss W.E., Oates J.A., Roberts L.J. Increase in circulating products of lipid peroxidation (F2-isoprostane) in smokers. N. Engl. J. Med. 1995, 332:1198-1203.
103. Movahed A., Yu L., Thandapilly S.J., Louis X.L., Netticadan T. Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury. Arch. Biochem. Biophys. 2012, 527:74-80.
104. Nakata R., Takahashi S., Inoue H. Recent advances in the study on resveratrol. Biol. Pharm. Bull. 2012, 35(3):273-279.
105. Narayanan N.K., Nargi D., Randolph C., Narayanan B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int. J. Cancer 2009, 125:1-8.
106. Ndisang J.F., Lane N., Syed N., Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 2010, 151:549-560.
107. Nicholson S.K., Tucker G.A., Brameld J.M. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br. J. Nutr. 2010, 103:1398-1403.
108. Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., Falcone S., Valerio A., Cantoni O., Clementi E., Moncada S., Carruba M.O. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310(5746):314-317.
109. Nonomura S., Kanagawa H., Makimoto A. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jokon (Polygonum cuspidatum SIEB. et ZUCC.). Yakugaku Zasshi 1963, 83:988-990.
110. Nunes T., Almeida L., Rocha J.F., Falcão A., Fernandes-Lopes C., Loureiro A.I., Wright L., Vaz-da-Silva M., Soares-da-Silva P. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. J. Clin. Pharmacol. 2009, 49:1477-1482.
111. Olas B., Wachowicz B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb. Res. 2002, 106:143-148.
112. Olas B., Wachowicz B., Bald E., Glowacki R. The protective effects of resveratrol against changes in blood platelet thiols induced by platinum compounds. J. Physiol. Pharmacol. 2004, 55:467-476.
113. Orallo F., Alvarez E., Camiña M., Leiro J.M., Gómez E., Fernández P. The possible implication of trans-Resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol. Pharmacol. 2002, 61:294-302.
114. Otterbein L.E., Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:1029-1037.
115. Pacher P., Szabo C. Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes. Curr. Opin. Pharmacol. 2006, 6:136-141.
116. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
117. Palsamy P., Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic b-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell. Physiol. 2010, 224:423-432.
118. Papa S., Skulachev V.P. Reactive oxygen species, mitochondria, apoptosis and aging. Mol. Cell. Biochem. 1997, 174:305-319.
119. Patel N.V., Gordon M.N., Connor K.E., Good R.A., Engelman R.W., Mason J., Morgan D.G., Morgan T.E., Finch C.E. Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models. Neurobiol. Aging 2005, 26(7):995-1000.
120. Paul B., Masih I., Deopujari J., Charpentier C. Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India. J. Ethnopharmacol. 1999, 68:71-76.
121. Pearce V.P., Sherrell J., Lou Z., Kopelovich L., Wright W.E., Shay J.W. Immortalization of epithelial progenitor cells mediated by resveratrol. Oncogene 2008, 27:2365-2374.
122. Polycarpou E., Meira L.B., Carrington S., Tyrrell E., Modjtahedi H., Carew M.A. Resveratrol 3-O-d-glucuronide and resveratrol 4'-O-d-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Mol. Nutr. Food Res. 2013, 10.1002/mnfr.201200742.
123. Prasad K. Resveratrol, wine, and atherosclerosis. Int. J. Angiol. 2012, 21:7-18.
124. Puca A.A., Carrizzo A., Ferrario A., Villa F., Vecchione C. Endothelialnitric oxidesynthase, vascular integrity and human exceptional longevity. Immun. Ageing 2012, 9:26.
125. Puca A.A., Carrizzo A., Villa F., Ferrario A., Casaburo M., Maciag A., Vecchione C. Vascular ageing: the role of oxidative stress. Int. J. Biochem. Cell Biol. 2013, 45(3):556-559.
126. Rains J.L., Jain S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 2011, 50:567-575.
127. Rakici O., Kiziltepe U., Coskun B., Aslamaci S., Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int. J. Cardiol. 2005, 105:209-215.
128. Ramprasath V.R., Jones P.J.H. Anti-atherogenic effects of resveratrol. Eur. J. Clin. Nutr. 2010, 64(7):660-668.
129. Räthel T.R., Samtleben R., Vollmar A.M., Dirsch V.M. Activation of endothelial nitric oxide synthase by red wine polyphenols: impact of grape cultivars, growing area and the vinification process. J. Hypertens. 2007, 25:541-549.
130. Ray P.S., Maulik G., Cordis G.A., Bertelli A.A., Bertelli A., Das D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Rad. Biol. Med. 1999, 27:160-169.
131. Rivière C., Richard T., Quentin L., Krisa S., Mérillon J.M., Monti J.P. Inhibitory activity of stilbenes on Alzheimer's β-amyloid fibrils in vitro. Bioorg. Med. Chem. 2007, 15(2):1160-1167.
132. Rocha K.K.R., Souza G.A., Ebaid G.X., Seiva F.R.F., Cataneo A.C., Novelli E.L.B. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem. Toxicol. 2009, 47(6):1362-1367.
133. Romero-Pérez A.I., Ibern-Gómez M., Lamuela-Raventós R.M., de La Torre-Boronat M.C. Piceid, the major resveratrol derivative in grape juices. J. Agric. Food Chem. 1999, 47(4):1533-1536.
134. Ryan M.J., Jackson J.R., Hao Y., Williamson C.L., Dabkowski E.R., Hollander J.M., Alway S.E. Suppression of oxidative stress by resveratrol after isometric contractions in gastrocnemius muscles of aged mice. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65(8):815-831.
135. Sabán R.J., Alonso A., Fabregate M., de la Puerta G.Q.C. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation. Antiinflamm. Antiallergy Agents Med. Chem. 2013, 12(1):94-99.
136. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat. Res. 2008, 658(1-2):68-94.
137. Salim S., Asghar M., Chugh G., Taneja M., Xia Z., Saha K. Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance. Brain Res. 2010, 1359:178-185.
138. Sato M., Suzuki Y., Okuda T., Yokotsuka K. Contents of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan. Biosci. Biotechnol. Biochem. 1997, 61(11):1800-1805.
139. Scapagnini G., Vasto S., Abraham N.G., Caruso C., Zella D., Galvano F. Modulation of nrf2/are pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol. Neurobiol. 2011, 44(2):202.
140. Shah A.M., Channon K.M. Free radicals and redox signalling in cardiovascular disease. Heart 2004, 90:486-487.
141. Sharma S., Kumar A., Arora M., Kaundal R.K. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes. Free Radic. Res. 2009, 43:400-408.
142. Sharma S., Misra C.S., Arumugam S., Roy S., Shah V., Davis J.A., Shirumalla R.K., Ray A. Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytother. Res. 2011, 25:67-73.
143. Siemann E.H., Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 1992, 43:49-52.
144. Singh C.K., Kumar A., Hitchcock D.B., Fan D., Goodwin R., LaVoie H.A., Nagarkatti P., DiPette D.J., Singh U.S. Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Mol. Nutr. Food Res. 2011, 55:1186-1196.
145. Singh K.C., Kumar A., LaVoie A.L., Di Pipette D.J., Singh U.S. Diabetic complications in pregnancy: is resveratrol a solution?. Exp. Biol. Med. 2013, 1-9.
146. Sinha K., Chaudhary G., Gupta Y.K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 2002, 71:655-665.
147. Smoliga J.M., Vang O., Baur J.A. Challenges of translating basic research into therapeutics: resveratrol as an example. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 67:158-167.
148. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem. 1997, 30:91-113.
149. Soufi F.G., Mohammad-Nejad D., Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor kB - apoptosis pathway. Pharmacol. Rep. 2012, 64:1505-1514.
150. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 2000, 235:1043-1045.
151. Takahashi S., Nakashima Y. Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells. Br. J. Nutr. 2011, 104:1-7.
152. Takahashi S., Uchiyama T., Toda K. Differential effect of resveratrol on nitric oxide production in endothelial f-2 cells. Biol. Pharm. Bull. 2009, 32:1840-1843.
153. Tang B.L., Chua C.E.L. SIRT1 and neuronal diseases. Mol. Asp. Med. 2008, 29(3):187-200.
154. Tanno M., Kuno A., Yano T., Miura T., Hisahara S., Ishikawa S., Shimamoto K., Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 2010, 285:8375-8382.
155. Timmers S., Konings E., Bilet L., Houtkooper R.H., van de Weijer T., Goossens G.H., Hoeks J., van der Krieken S., Ryu D., Kersten S., Moonen-Kornips E., Hesselink M.K., Kunz I., Schrauwen-Hinderling V.B., Blaak E.E., Auwerx J., Schrauwen P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011, 14:612-622.
156. Timmers S., Auwerx J., Schrauwen P. The journey of resveratrol from yeast to human. Aging. 2012, 4:3.
157. Turrens J.F., Lariccia J., Nair M.G. Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Radic. Res. 1997, 27:557-562.
158. Ungvari Z., Labinskyy N., Mukhopadhyay P., Pinto J.T., Bagi Z., Ballabh P., Zhang C., Pacher P., Csiszar A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am. J. Physiol. Heart. Circ. Physiol. 2009, 297:H1876-H1881.
159. Vang O., Ahmad N., Baile C.A., Baur J.A., Brown K., Csiszar A., Das D.K., Delmas D., Gottfried C., Lin H.Y., Ma Q.Y., Mukhopadhyay P., Nalini N., Pezzuto J.M., Richard T., Shukla Y., Surh Y.J., Szekeres T., Szkudelski T., Walle T., Wu J.M. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE 2011, 6:e19881.
160. Vecchione C., Aretini A., Marino G., Bettarini U., Poulet R., Maffei A., Sbroggiò M., Pastore L., Gentile M.T., Notte A., Iorio L., Hirsch E., Tarone G., Lembo G. Selective Rac-1 inhibition protects from diabetes-induced vascular injury. Circ. Res. 2006, 98(2):218-225.
161. Vecchione C., Gentile M.T., Aretini A., Marino G., Poulet R., Maffei A., Passarelli F., Landolfi A., Vasta A., Lembo G. A novel mechanism of action for statins against diabetes-inducedoxidative stress. Diabetologia 2007, 50(4):874-880.
162. Vecchione C., Carnevale D., Di Pardo A., Gentile M.T., Damato A., Cocozza G., Antenucci G., Mascio G., Bettarini U., Landolfi A., Iorio L., Maffei A., Lembo G. Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 2009, 54(5):1028-1034.
163. Vecchione C., Frati A., Di Pardo A., Cifelli G., Carnevale D., Gentile M.T., Carangi R., Landolfi A., Carullo P., Bettarini U., Antenucci G., Mascio G., Busceti C.L., Notte A., Maffei A., Cantore G.P., Lembo G. Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension 2009, 54(1):150-156.
164. Vincent A.M., Russell J.W., Sullivan K.A., Backus C., Hayes J.M., McLean L.L., Feldman E.L. SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp. Neurol. 2007, 208:216-227.
165. Waite K.A., Sinden M.R., Eng C. Phytoestrogen exposure elevates PTEN levels. Hum. Mol. Genet. 2005, 14:1457-1463.
166. Walle T. Bioavailability of resveratrol. Ann. NY Acad. Sci. 2011, 1215:9-15.
167. Walle T., Hsieh F., DeLegge M.H., Oatis J.E., Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32:1377-1382.
168. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002, 106:1652-1658.
169. Wang Y.I., He F., Li X.L. The neuroprotection of resveratrol in the experimental cerebral ischemia. Zhonghua Yi Xue Za Zhi. 2003, 83(7):534-536.
170. Wang D., Hang T., Wu C., Liu W. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 829:97-106.
171. Wang N., Ko S.H., Chai W., Li G., Barrett E.J., Tao L., Cao W., Liu Z. Resveratrol recruits rat muscle microvasculature via a nitric oxidedependent mechanism that is blocked by TNFα. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E195-E201.
172. Wang W., Yan C., Zhang J., Lin R., Lin Q., Yang L., Ren F., Zhang J., Ji M., Li Y. SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis 2013, 18(6):689-701.
173. Yang F., Zhang T., Ito Y. Large-scale separation of resveratrol, anthraglycoside A and anthraglycoside B from Polygonum cuspidatum Sieb. et Zucc by high-speed counter-current chromatography. J. Chromatogr. A 2001, 919:443-448.
174. Yang J., Dong S., Jiang Q., Kuang T., Huang W., Yang J. Changes in expression of manganese superoxide dismutase, copper and zinc superoxide dismutase and catalase in Brachionus calyciflorus during the aging process. PLoS One 2013, 8:57186.
175. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., Wierzbicki M., Verbeuren T.J., Cohen R.A. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
176. Zhang H., Zhang J., Ungvari Z., Zhang C. Resveratrol improves endothelial function-role of TNFα and vascular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1164-1171.
177. Zhang H., Morgan B., Potter B.J., Ma L., Dellsperger K.C., Ungvari Z., Zhang C. Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am. J. Physiol. Heart. Circ. Physiol. 2010, 299:H985-H994.
178. Zhang J., Chen J., Yang J., Xu C.W., Pu P., Ding J.W., Jiang H. Resveratrolattenuatesoxidativestressinducedbyballooninjuryin theratcarotidarterythroughactionson the ERK1/2andNF-kappaBpathway. Cell. Physiol. Biochem. 2013, 31(2-3):230-241.
179. Zhuang H., Kim Y.S., Koehler R.C., Doré S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons Ann. N. Y. Acad. Sci. 2003, 993:276-288.